Moderna, Inc. (NASDAQ:MRNA) stock popped after positive news about the company’s coronavirus vaccine candidate. After the shares climbed 20% to record highs, the company announced plans to sell $1.25 billion in new shares to fund manufacturing and distribution of its vaccine candidate. Update on Moderna’s coronavirus vaccine Moderna’s coronavirus vaccine is officially referred to as […] …read more
Source:: Yahoo Finance
